Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for cell therapy
Thinking beyond the sequence: CAR-T cell therapy litigation at the UPC (2seventy bio v Johnson & Johnson, UPC_CFI_029/2026) Thinking beyond the sequence: CAR-T cell therapy litigation at the UPC (2seventy bio v Johnson & Johnson, UPC_CFI_029/2026) Reviewed by Dr Rose Hughes on Monday, August 17, 2026 Rating: 5
Navigating the complex LNP IP landscape Navigating the complex LNP IP landscape Reviewed by Dr Rose Hughes on Wednesday, May 06, 2026 Rating: 5
Patenting stem cell therapies in the US: The role and risks of product-by-process claims (Restem v Jadi cell) Patenting stem cell therapies in the US: The role and risks of product-by-process claims (Restem v Jadi cell) Reviewed by Dr Rose Hughes on Sunday, March 29, 2026 Rating: 5
The validity and value of cell therapy safety protocol inventions (T 1555/23) The validity and value of cell therapy safety protocol inventions (T 1555/23) Reviewed by Dr Rose Hughes on Friday, February 27, 2026 Rating: 5
A new way to define T cells and what it means for cell therapy IP A new way to define T cells and what it means for cell therapy IP Reviewed by Dr Rose Hughes on Monday, January 19, 2026 Rating: 5
The reproducibility challenge for advanced therapies (T 0827/23) The reproducibility challenge for advanced therapies (T 0827/23) Reviewed by Dr Rose Hughes on Monday, August 04, 2025 Rating: 5
Pitfalls of cell therapy manufacturing IP - A case study (T 0868/23) Pitfalls of cell therapy manufacturing IP - A case study (T 0868/23) Reviewed by Dr Rose Hughes on Monday, July 07, 2025 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.